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Abstract - We measured the effect of an antiviral drug and vitamins on dopamine, 5-HIAA and some oxidative biomarkers 
in the brain of rats exposed to ozone. Groups of Wistar rats received intraperitoneally for 5 days: G1 (control) - 0.9% NaCl; 
G2 - oseltamivir (an antiviral); G3 - multivitamins (vitamins A, C and D). A similar assay was realized in rats exposed to 
ozone. The brain was excised and dissected into the cortex, hemispheres, cerebellum and medulla/oblongata to measure 
the levels dopamine, GSH and lipid peroxidation. Levels of 5-HIAA increased in the cerebellum/medulla oblongata of rats 
that received vitamins and ozone. Dopamine increased in all regions of the groups that received oseltamivir in the presence 
of ozone. GSH increased in the hemispheres and cerebellum/medulla oblongata only in groups that received oseltamivir 
and ozone. We found that vitamins and oseltamivir altered serotonin metabolism in the brains of young rats. Oxidative 
stress may be involved in these effects. 
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INTRODUCTION
Oseltamivir, a neuraminidase inhibitor, is an effec-
tive antiviral, amply used for the treatment of both 
seasonal flu and H5N1 influenza A virus infections. 
The most common adverse effects are nausea and 
vomiting, however, neuropsychiatric behaviors such 
as jumping and falling from balconies have been re-
ported in young patients (Yoshino et al., 2008), sug-
gesting that the increase in dopamine in oseltamivir 
treatment may lead to abnormal behavior in young 
patients. The pharmacological mechanism of the neu-
ropsychiatric effects of oseltamivir remains unclear 
not only in adults but also in the very young pediatric 
population. Today, oseltamivir is being stockpiled by 
Mexican governments as a first line of treatment for 
an anticipated outbreak of swine influenza caused by 
AH1N1, which came into effect in late March 2009 
due to an outbreak of a respiratory illness that was 
later proved to be caused by the H1N1 (S-OIV) virus 
– a novel swine-origin influenza A. 64% of chronic 
obstructive  pulmonary  disease  (COPD)  exacerba-
tions are attributed to respiratory infections, includ-
ing influenza (strains A and B). These infections af-
fect the airway epithelium, provoking inflammatory 
and apoptotic events through mechanisms involving 
the generation of reactive oxygen species (ROS) in-
volved in the deterioration of a patient’s health dur-
ing the course of the disease (Mata et al., 2011).
Environmental pollution or exposure to ozone 
generates reactive oxygen species and other oxida-1372 D. CALDERÓN GUZMÁN ET AL.
tive stressors, which may initiate and augment in-
flammation (Dozor, 2010), thereby altering the neu-
rotransmitter systems (Biermann et al., 2009). Many 
therapeutic  strategies  to  decrease  oxidative  stress 
have been suggested. Such strategies include dietary 
changes, use of antioxidant vitamins and minimiz-
ing the exposure of young children to environmental 
ozone (Chabra et al., 2010). 
It is common to find the clinical parameters of 
vitamin deficiency, even when the minimum daily 
requirements are met, in patients admitted to the In-
tensive Care Unit due to complications of pneumonia 
as a consequence of seasonal flu (Thompson et al., 
2003). For this, it was suggested that daily parenteral 
supplements of these elements should be higher than 
those recommended by the American Medical As-
sociation (AMA) (Hence-Morilla et al., 1990). Like-
wise, there are some supplements with A, C and D 
vitamins such as Aderogyl® for daily intake that are 
applied to offset this deficiency (PLM, 1999). GSH 
is the main redox equilibrium regulator and protec-
tor of the tissues suffering from damage by oxidative 
agents. It is also a ubiquitous reducing agent and the 
absence  can  occur  in  severe  oxidative  stress  (OS) 
(Driver et al., 2000).
Recent studies have indicated that the use of mi-
cronutrients  induces  defensive  mechanisms  in  the 
brain by diminishing free radical-induced lipid per-
oxidation (Bediz et al., 2006). Free radicals (FR) are 
reactive oxygen or nitrogen species with impaired 
electrons,  which  may  induce  oxidative  damage  to 
biologically important molecules, though membrane 
lipids are the main target (Beckman et al., 1990), and 
the central nervous system (CNS) is particularly sus-
ceptible to this type of damage.
Membrane lipids are known to strongly interact 
with the lipid bilayer structural proteins (Swapna 
et al., 2005), such as Na+-K+ ATPase, which is re-
sponsible for ion interchange across the membrane 
(Neault et al., 2001). The inhibition of Na+-K+ AT-
Pase promotes the excitatory amino acid release in 
CNS (Hernandez, 1982), which induces antioxidant 
activity on damaged tissues (Muñoz et al., 2006). 
Therefore, it is necessary to determine the effects 
of  oseltamivir  and  vitamins  in  order  to  establish 
methods for safe administration using experimen-
tal ozone exposure. The aim of this study rose from 
the above necessity and focused on determining the 
effects of these substances on dopamine levels and 
some biomarkers of oxidative stress in the brain re-
gions of juvenile rats.
MATERIALS AND METHODS
Forty male Wistar rats, each weighing about 80 g, 
were  divided  into  six  experimental  groups,  three 
were maintained in the absence, and three in the 
presence of ozone, and were given oseltamivir and 
Aderogyl® as follows: Group 1 (n=6) control; group 
2  (n=7)  oseltamivir  (20  mg/kg);  group  3  (n=7) 
Aderogyl® (150 ml/rat). All treatments were given 
intraperitoneally every 24 h for 5 days. Each 150 μl 
of aderogyl solution contained a mixture of vita-
mins A (390UI), C (30mg) and D (60UI). The rats 
were killed by decapitation 30 min after receiving 
the last dose of oseltamivir and aderogyl® and the 
brains were extracted and placed in 0.9% NaCl at 
4°C. Brain dissection was carried out in the cortex, 
hemispheres, cerebellum/medulla oblongata; sam-
ples were homogenized in 10 volumes of TRIS-HCl 
0.05M, pH 7.4 for the assessment of lipid peroxida-
tion (TBARS) and Na+, K+ ATPase. An aliquot of 
this was taken and combined with perchloric acid 
(HClO4) 0.1 M, (50:50 v/v) to measure the levels 
of glutathione (GSH), dopamine and 5-HIAA. All 
experimental procedures were carried out accord-
ing to the rules of the Laboratory Animals Use and 
Care Committee of international institutions.
Measurement of dopamine (DA)
The DA levels were measured in the supernatant of 
tissue homogenized in HClO4 after centrifugation at 
9000 rpm for 10 min in a microcentrifuge (Hettich 
Zentrifugen, model Mikro 12-42, Germany), based 
on the technique reported by Calderon et al. (2008). 
An aliquot of the HClO4 supernatant and 1.9 ml of 
buffer  (0.003  M  octyl-sulphate,  0.035  M  KH2PO4, 
0.03 M citric acid, 0.001 M ascorbic acid) were placed ANTIVIRAL AND OZONE EFFECTS IN RAT BRAIN 1373
in a test tube. The mixture was incubated for 5 min 
at room temperature in total darkness, and subse-
quently, the samples were read in a spectrofluorom-
eter (Perkin Elmer LS 55, England) at 282 nm excita-
tion and 315 nm emission. The FL Win Lab version 
4.00.02 software was used. Values were inferred in a 
previously standardized curve and reported as nM/g 
of wet tissue.
Measurement of 5-hydroxyindol acetic acid (5-HIAA)
The levels of 5-HIAA were measured in the super-
natant of tissue homogenized in HClO4 after cen-
trifugation for 10 min in a microcentrifuge (Mikro 
12-42, Germany), with a modified version of the 
technique reported by Beck et al. (1977). An aliq-
uot of the HClO4 supernatant and 1.9 ml of acetate 
buffer 0.01M pH 5.5 were placed in a test tube. The 
mixture was incubated for 5 min at room tempera-
ture in total darkness, and subsequently, the samples 
were read in a spectrofluorometer (Perkin Elmer LS 
55, England) with 296 nm excitation and 333 nm 
emission lengths. The FL Win Lab version 4.00.02 
software was used. Values were inferred in a previ-
ously standardized curve and reported as nMoles/g 
of wet tissue.
Measurement of glutathione (GSH)
The levels of GSH were measured from a sample of 
the floating tissue homogenized in HClO4 obtained 
after centrifugation for 5 min in a microcentrifuge 
(Mikro 12-42, Germany), according to the technique 
reported by Hissin and Hilf (1976). An aliquot of 
20µl of the floating tissue in HClO4 with 1.8ml of 
phosphate buffer at pH 8.0 with EDTA at 0.2%, and 
100µl of ortho-phthaldialdehyde (OPT) in concen-
tration of 1mg/ml in methanol were put in an assay 
tube and incubated for 15 min at ambient tempera-
ture in total darkness. At the end of the incubation, 
the samples were read in a Perlin Elmer LS 55 spec-
trofluorometer (excitation 350mm; emission of 420 
nm). FL Win Lab version 4.00.02 software was used. 
The values were obtained from a previously stand-
ardized standard curve and were reported in nM/g 
of wet tissue.
Measurement of lipid peroxidation (TBARS)
TBARS  determination  was  carried  out  using  the 
modified  technique  of  Gutteridge  and  Halliwell 
(1990), as described below. From the homogenized 
brain in TRIS HCl 0.05 M pH 7.4, 1 ml was taken and 
mixed with 2 ml of thiobarbituric acid (TBA) con-
taining 1.25 g of TBA, 40 g of trichloroacetic acid and 
6.25 ml of concentrated HCl diluted in 250 ml deion-
ized H2O. The mixture was heated to boiling (Ther-
momix 1420). The samples were placed in an ice bath 
for 5 min and centrifuged at 700 g for 15 min (Sor-
vall RC-5B Dupont). The absorbance of the floating 
tissues was read in triplicate at 532 nm in a spectro-
photometer (Helios de UNICAM). The concentra-
tion of reactive substances to the thiobarbituric acid 
(TBARS) was expressed in µM of malondialdehyde/g 
of wet tissue.
Measurement of total ATPase
The technique was carried out by using approxi-
mately 1 mg of the brain homogenate in 0.05M TRIS 
HCl at pH 7.4. This was incubated for 15 min in a 
medium that contained 3 mM MgCl2, 7 mM KCl, 
100 mM NaCl, with or without ouabain 0.06 mM; 4 
mM of TRIS-ATP was added to the homogenate af-
ter 15 min of incubation; the sample was incubated 
for 30 min at 37ºC with agitation in a Dubnoff Lab-
conco water bath. The reaction was stopped by the 
addition of 100 µl of 10% trichloroacetic acid. The 
samples were centrifuged at 3500 rpm for 5 min at 
4 ºC (Calderon-Guzman et al., 2005), and an aliq-
uot of the floating tissue was used to measure in-
organic phosphate (Pi) using the method proposed 
by Fiske and Subarrow (1925). The absorbance of 
the floating tissue was measured at 660 nm using 
Helios of UNICAM spectrophotometer. Total AT-
Pase absorbance was then measured in the absence 
of ouabain, and their activity was expressed in µM 
Pi/g of wet tissue/min.
Analysis of results
Kruskal-Wallis statistical test and analysis of vari-
ance (ANOVA) with their respective contrasts after 1374 D. CALDERÓN GUZMÁN ET AL.
being subjected to a variance homogeneity test. The 
values of p<0.05 were considered statistically signifi-
cant (Castilla-Serna and Cravioto, 1991). To carry 
out the tests, JMP Statistical Discovery Software ver-
sion 6.0.0 from SAS was used.
RESULTS
The levels of dopamine in brain regions of young rats 
treated with oseltamivir and aderogyl® in the pres-
ence of air and ozone is shown in Fig. 1. The concen-
Fig. 1. Dopamine levels in brain regions of young rats treated with oseltamivir and aderogyl® in the presence of air (A) and ozone (O). 
Mean values ± SD. Ctrl = Control, Osel = Oseltamivir, Ader = Aderogyl®. *p<0.05 Kruskal-Wallis test.
Fig. 2. 5-HIAA levels in brain regions of young rats treated with oseltamivir and aderogyl® in the presence of air (A) and ozone (O). 
Mean values ± SD. Ctrl = Control, Osel = Oseltamivir, Ader = Aderogyl®. *p<0.05 Kruskal-Wallis test.ANTIVIRAL AND OZONE EFFECTS IN RAT BRAIN 1375
tration of DA in the cortex, hemispheres and cerebel-
lum/medulla oblongata increased (p<0.001) after the 
Kruskal-Wallis test for the groups of rats that received 
oseltamivir or aderogyl® plus ozone, compared to the 
control groups. In the same regions, this biomarker 
decreased significantly (p<0.02) in the groups of rats 
that received oseltamivir when compared with the 
group that received aderogyl®. The concentration of 
5-HIAA increased (p<0.05) in cerebellum/medulla 
oblongata of the group that received vitamins and 
ozone (Fig. 2). 
The levels of GSH in the hemispheres and cer-
ebellum/medulla oblongata increased in young rats 
Fig. 3. GSH levels in brain regions of young rats treated with oseltamivir and aderogyl® in the presence of air (A) and ozone (O). Mean 
values ± SD. Ctrl = Control, Osel = Oseltamivir, Ader = Aderogyl®. *p<0.05 Kruskal-Wallis test.
Fig. 4. TBARS levels in brain regions of young rats treated with oseltamivir and aderogyl® in the presence of air (A) and ozone (O). Mean 
values ± SD. Ctrl = Control, Osel = Oseltamivir, Ader = Aderogyl®. *p<0.05 Kruskal-Wallis test.1376 D. CALDERÓN GUZMÁN ET AL.
treated with aderogyl® and oseltamivir in the pres-
ence of ozone and in those treated with aderogyl® 
in the presence of air under the Kruskal-Wallis test 
(p<0.001) when compared with the control group 
(Fig. 3).
The concentration of lipid peroxidation in the 
young rats treated with oseltamivir and aderogyl® in 
the presence of air and ozone decreased (p<0.001) 
in the cortex and hemisphere regions on application 
of the Kruskal-Wallis test compared to the control 
group (Fig. 4). In addition, in the same regions this 
biomarker increased (p<0.005) in the group treated 
with aderogyl®. 
The  activity  of  total  ATPase  increased  in  the 
hemisphere regions of the groups that received os-
eltamivir or aderogyl® combined with ozone, while 
in  the  cerebellum/medulla  oblongata  regions  this 
activity declined in the group that received oseltami-
vir in the presence of ozone; the Kruskal-Wallis test 
showed  differences  (p=0.007)  with  respect  to  the 
control group (Fig. 5).
DISCUSSION AND CONCLUSIONS
It has been reported that neurological complications 
can occur following respiratory tract infection by the 
novel influenza A (H1N1) virus, and that the central 
nervous system side effects observed with oseltami-
vir phosphate and its active metabolite are probably 
be due to their inflammatory effect (Oshima et al., 
2009). Ozone elicits a broad spectrum of airway anti-
oxidant responses, with an initial loss of vitamin C, 
followed by a phase of augmentation of low-molecu-
lar-weight antioxidant concentrations at the air-lung 
interface (Behndig et al., 2009).
In our study, the concentration of dopamine 
increased with oseltamivir treatment in presence of 
ozone in all brain regions. Probably this effect oc-
curred on neurons that contain dopamine hydroxy-
lase and phenylethanolamine N-methyltransferase, 
in whose metabolic pathways dopamine is changed 
to  noradrenaline  and  adrenaline,  respectively 
(BPC, 1992). The levels of dopamine decreased in 
rats with vitamin treatments in the group exposed 
Fig. 5. Total ATPase activity on brain regions of young rats treated with oseltamivir and aderogyl® in the presence of air (A) and ozone 
(O). Mean values ± SD. Ctrl = Control, Osel = Oseltamivir, Ader = Aderogyl®. *p<0.05 Kruskal-Wallis test.ANTIVIRAL AND OZONE EFFECTS IN RAT BRAIN 1377
to ozone. These results are in accordance with the 
reports of Brook et al. (2009) and Valacchi et al. 
(2009) who suggested that there is a protective ef-
fect against the presence of endogenous metabolic 
and external radicals. Indeed, dietary supplemen-
tation with antioxidant vitamins A, C, and D pro-
vides a variable degree of protection against this 
enhancement.
The presence of ozone combined with oseltami-
vir induced an increase of dopamine. This means that 
both substances have an additive effect. Its increase 
agrees with the reports of Yoshino et al. (2008), who 
found the same increase in their study and proposed 
that this increase in dopamine during oseltamivir 
treatment may have caused abnormal behaviors in 
young  patients.  Consequently,  the  prescription  of 
oseltamivir in the treatment of viral ailments in chil-
dren requires a strict measure of observation and 
vigilance. 
The levels of 5-HIAA decreased with the admin-
istration of vitamins in the absence of ozone and in-
creased when exposed to this substance. These find-
ings are in accordance with previous studies made 
in our lab (Barragan-Mejia et al., 2002), and with 
the study of Gonzalez and Paz (1997), where the oc-
currence of an increase of 5-HIAA in the midbrain 
during  ozone  exposure  was  reported  to  affect  the 
metabolism of major neurotransmitter systems after 
1 h of exposure. This suggests that ozone alters the 
metabolism of serotonin.
Oseltamivir produces side effects on the central 
nervous system, especially when it is combined with 
other agents such as ethanol (Izumi et al., 2007). Be-
sides, it is necessary to consider that there are genetic 
differences between Japanese and Caucasian patients 
that result in different levels of oseltamivir and/or 
oseltamivir carboxylate in the CNS. These genetic 
differences influence the metabolism and pharma-
cological activity of the drug in the CNS. Perhaps 
similar things occurred in the present study because 
the capacity for converting oseltamivir to oseltamivir 
carboxylate in rat and human brains was low (Toovey 
et al., 2008). 
Based on the results of the present study, it can be 
suggested that the combination of oseltamivir with 
ozone  induces  changes  in  dopaminergic  receptors 
and at the same time, provokes a pro-oxidant effect 
in the brain.
The concentration of GSH in the brain increased 
in the experimental groups that received oseltamivir 
in the presence of ozone. This effect may be due to 
the accumulation of this drug in brain as suggested 
by Morimoto et al. (2008). These authors proposed 
that the interindividual variation of P-glycoprotein 
activity might be an important factor, determining 
susceptibility to the CNS side effect of this drug, and 
therefore possibly playing a role in increasing the ac-
cumulation of oseltamivir in the brain because of the 
immature blood brain barrier in young animals (Jo-
hanson, 1980).
Some studies suggest that the presence of osel-
tamivir in the brain reduced the generation of en-
dogenous nitric oxide (NO) (Kacergius et al., 2006), 
meaning that this increase could hike up a neuropro-
tective effect as was suggested by the findings of Ju et 
al. (2005). The later proposal that S-nitrosoglutath-
ione (GSNO), a potent endogenous antioxidant de-
rived from the interaction between nitric oxide and 
glutathione,  caused  dose-dependent  protective  ef-
fects against amyloid beta (Abeta)/ceramide neuro-
toxicity for inhibition of caspase activation and pro-
duction of reactive oxygen species (ROS). It seemed 
that the activation of cGMP-dependent protein ki-
nase  (PKG),  phosphatidylinositol  3-kinase  (PI3K) 
and extracellular signal-regulated kinase (ERK) are 
involved in this GSNO-mediated neuroprotection.
The levels of lipid peroxidation decreased with 
the administration of oseltamivir or vitamins on the 
hemispheres and cerebellum/medulla oblongata of 
animals with ozone exposure. This is contrary to the 
result obtained with GSH levels in the same condi-
tion.  The  decrease  of  lipoperoxidation  was  more 
evident in ozone-exposed groups treated with os-
eltamivir and vitamins, due to the additive effects. 
These results suggest that the downward tendency 
of lipoperoxidation is due to the antioxidant effect 1378 D. CALDERÓN GUZMÁN ET AL.
induced by the carboxylate of oseltamivir, the ac-
tive metabolite of the drug (Fuke et al., 2008), whose 
chemical characteristic is the attraction of electrons 
to the same molecule.
On  the  other  hand,  the  total  ATPase  activity 
increased after administration of oseltamivir in the 
hemisphere regions; the basal state was recovered in 
the presence of vitamins. This suggests that the sub-
stances administered exert an effect on the presence 
of intracellular ions, particularly calcium and sodium 
ions (Brase, 1990), thereby modifying the membrane 
potential,  probably  through  the  dopamine  trans-
porter, a membrane protein specifically expressed by 
dopaminergic neurons, which is regulated by Zn2+ 
that directly interacts with the protein (Pilf et al., 
2009).
The results of the present study under conditions 
of ozone exposure suggest that oseltamivir and vita-
mins could be combined in the treatment of influ-
enza A (H1N1) virus infection because they induce 
an antioxidant effect in the brain. This means that if 
oseltamivir is administered to urban children with 
environmental ozone exposure as the first choice of 
drug for the treatment of influenza, and these chil-
dren consume vitamins in their daily diet, a benefi-
cial effect on the brain will be induced by the combi-
nation of these substances as suggested by the results 
of this study.
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